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A B S T R A C T
Background
It is important to seek cost-effective methods of improving the care and outcome of those with serious mental illnesses. User-held
records, where the person with the illness holds all or some personal information relating to the course and care of their illness, are now
the norm in some clinical settings. Their value for those with severe mental illnesses is unknown.
Objectives
To evaluate the effects of personalised, accessible, user-held clinical information for people with a severe mental illness (defined as
psychotic illnesses).
Search methods
We updated previous searches by searching the Cochrane Schizophrenia Group Trials Register in August 2011. This register is compiled
by systematic searches of major databases, and handsearches of journals and conference proceedings.
Selection criteria
We included all relevant randomised controlled trials (RCTs) that:
i. have recruited adult participants with a diagnosis of a severe mental illness (specifically psychotic illnesses and severe mood disorders
such as bipolar and depression with psychotic features); and
ii. compared any personalised and accessible clinical information held by the user beyond standard care to standard information
routinely held such as appointment cards and generic information on diagnosis, treatment or services available.
Data collection and analysis
Study selection and data extraction were undertaken independently by two authors and confirmed and checked by a third.We contacted
authors of trials for additional and missing data. Where possible, we calculated risk ratios (RR) and 95% confidence intervals (CI). We
used a random-effects model. We assessed risk of bias for included studies and created a ’Summary of findings’ table using GRADE.
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Main results
Four RCTs (n = 607) of user-held records versus treatment as usual met the inclusion criteria. When the effect of user-held records
on psychiatric hospital admissions was compared with treatment as usual in four studies, the pooled treatment effect showed no
significant impact of the intervention and was of very low magnitude (n = 597, 4 RCTs, RR 0.99 CI 0.71 to 1.38, moderate quality
evidence). Similarly, there was no significant effect of the intervention in three studies which investigated compulsory psychiatric
hospital admissions (n = 507, 4 RCTs, RR 0.64 CI 0.37 to 1.10, moderate quality evidence). Other outcomes including satisfaction
and mental state were investigated but pooled estimates were not obtainable due to skewed or poorly reported data, or only being
investigated by one study. Two outcomes (violence and death) were not investigated by the included studies. Two important randomised
studies are ongoing.
Authors’ conclusions
The evidence gap remains regarding user-held, personalised, accessible clinical information for people with psychotic illnesses for many
of the outcomes of interest. However, based on moderate quality evidence, this review suggests that there is no effect of the intervention
on hospital or outpatient appointment use for individuals with psychotic disorders. The number of studies is low, however, and further
evidence is required to ascertain whether these results are mediated by the type of intervention, such as involvement of a clinical team
or the type of information included.
P L A I N L A N G U A G E S U M M A R Y
Patient-held clinical information for people with psychotic illnesses
User-held information is where the ill person holds personal information about their care. Such records are becoming the norm in many
settings and are becoming more popular with patients. This is especially the case where the person concerned is not in hospital and
receives care from more than one professional. Providing people with information about their care is thought to increase their feelings
of involvement in their treatment and aims to increase people’s satisfaction and participation with services, ensure early treatment and
prevent hospital admission.
The value of user-held personal information for those with severe mental illnesses is not known however and research evaluating the
effectiveness is rare. Some research suggests that while many people decline the offer of a user-held record, the majority of those who
carry their records report this to be useful.
Based on a search in 2011, this review includes four trials with a total of 607 people and evaluates the effects of user-held information
for people with severe mental illness. In the main, the number of relevant studies is low, with poor reporting of some outcomes. Based
on moderate quality evidence, the review found that user-held information did not decrease hospital admissions, and did not decrease
compulsory admissions or encourage people with severe mental illness to attend appointments (when compared to treatment as usual).
Other important outcomes, such as satisfaction with care, costs and effect on mental health, were not available due to the limited
quality of the four studies. There is therefore a gap in knowledge and evidence regarding user-held information for people with severe
mental health problems. Further evidence is also required on the different types of user-held information (for example, if it involves the
mental health team and what type of information is included in the record). Large-scale, well-conducted and well-reported studies are
required to assess the effects of user-held information for people with mental illness. Two important randomised studies are currently
taking place. For the present, despite a gap in evidence, user-held information is low cost and acceptable to patients, so its use is likely
to grow. However, it cannot be assumed that user-held information is of benefit to people and is cost-effective without further large-
scale, well-conducted and well-reported trials.
This plain language summary has been written by a consumer, Benjamin Gray: Rethink Mental Illness. E-mail: ben.gray@rethink.org
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
User-held information versus Sstandard Information for routine care of people with severe mental illness
Patient or population: pat ients with rout ine care of people with severe mental illness
Settings: inpat ient and community (UK)
Intervention: user-held information versus standard information
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control USER-HELD INFORMA-
TION versus STAN-
DARD INFORMATION
Psychiatric hospital
admission: psychiatric
admission
Numbers admitted
Follow-up: mean 13
months
Low1 RR 0.99
(0.71 to 1.38)
597
(4 studies)
⊕⊕⊕©
moderate2
50 per 1000 49 per 1000
(35 to 69)
High1
440 per 1000 436 per 1000
(312 to 607)
Psychiatric hospital
admission: compul-
sory admission
Numbers admitted
Follow-up: mean 13
months
Low1 RR 0.64
(0.37 to 1.1)
507
(3 studies)
⊕⊕⊕©
moderate3
40 per 1000 26 per 1000
(15 to 44)
High1
260 per 1000 166 per 1000
(96 to 286)
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Death: causes other
than suicide - not re-
ported
See comment See comment Not est imable - See comment No study reported this
outcome
Violence - not reported See comment See comment Not est imable - See comment No study reported this
outcome
Mental state: psy-
chopathology
See comment See comment Not est imable 0
(3 studies)
See comment Data not pooled: stud-
ies used inconsis-
tent/ incompatible mea-
sures of psychopathol-
ogy and/ or data are
skewed. No indicat ion
of dif f erences between
groups
Satisfaction with
health care
See comment See comment Not est imable 0
(3 studies)
See comment Data not pooled: stud-
ies used inconsistent/
incompatible measures
of sat isfact ion and/ or
data are skewed. No in-
dicat ion of dif f erences
between groups
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Assumed risk: the low and high risk values correspond to the lowest and highest rates of admissions in the control groups
f rom the included studies.
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2 Imprecision: rated ’serious’ - The 95% conf idence interval around the pooled est imate is wide, it contains no ef fect,
appreciable benef it and appreciable harm as def ined by the GRADE system as a 25% risk decrease or increase respect ively.
3 Imprecision: rated ’serious’ - The 95% conf idence interval around the pooled est imate is wide, containing both no ef fect and
an appreciable benef it as def ined by the GRADE system as 25% risk reduct ion. There were also only 67 events in total.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
It is important to seek cost-effective methods of improving the
care and outcome of those with serious mental illnesses. User-
held records, where the person with the illness holds all or some
personal information relating to the course and care of their illness,
are now the norm in some clinical settings (Kaelber 2008). This is
particularly the case where the person concerned is not in hospital
and receives care frommore than one professional. User-held notes
are becoming popular for obstetric care (Brown 2004; Phipps
2001) both in developed and developing countries (Shah 1993).
Parent-held records are widely used in paediatric care (Bourgeois
2009; Ghossein 1998; Hampshire 2004). The management of
people with chronic disabilities such as stroke or cancer can also
involve user-held records (Banet 1997; Finlay 1999; Ko 2010;
Williams 2001).
Brief types of user-held information are available for use in
emergencies such as anaphylaxis and post-splenectomy infection
(Freeman 1998; Wharry 1996; Williams 1996). This type of in-
formation tends not to be comprehensive and the aims vary with
setting and condition. Nevertheless, as with the full notes, the aim
of these truncated personal record systems is to promote patient
participation in care, increase consumer satisfaction with services,
facilitate early treatment and help avoid hospital admission.
Both long and short forms of user-held information are now being
used for people with mental health problems (Backlar 1996; Essex
1990; Henderson 2004; Lester 2003; Pickersgill 1998; Reuler
1991; Stafford 1997; Sutherby1999; Swanson 2006a;Wolf 1996).
In certain countries legislation obligates the provision of a copy
of the treatment outline and professionals’ contact details to those
in receipt of specialist mental health services (DoH 1990). This
information is not specifically designed to be something patients
might wish to carry, nor to be of use in a crisis, but it may in
itself have an effect, so evaluation is justified. Another form of
personal information has recently emerged. Advance Statements
can be defined as statements regarding service user preferences for
future treatment (Henderson 2008). These are typically devised
and held by the service user and include such interventions as
Psychiatric Advance Directives, Joint Crisis Plans (Sutherby 1999)
and Wellness Recovery Actions Plans (Cook 2009).
Attempts at evaluation of the effects of user-held records for those
with long term mental illness are rare. There are several audit and
case series studies of the use of user-held records (Essex 1990;
Pickersgill 1998; Reuler 1991; Stafford 1997; Wolf 1996). These
suggest that while many people refuse the offer of a user-held
record, themajority of those who carry their records report this ac-
tivity to be useful (Stafford 1997). In theUSA, Psychiatric Advance
Directives (PADs) have been shown to be popular with service
users and their carers (Backlar 2001) and some professional groups
(Atkinson 2004). However, there are some concerns regarding the
implementation of wishes contained in PADs during crises from
both service users and clinicians (Atkinson 2004; Backlar 2001);
the ability of the service user to generate a valid PAD (Amering
2007; Atkinson 2004; Elbogen 2007); and questions regarding
their impact on or relationship to outcome (Backlar 2001). Ad-
ditionally, clinicians often express concern regarding the possi-
bility of service users requesting unreasonable treatments or in-
deed refusing treatment altogether (Atkinson 2004; Backlar 2001;
Elbogen 2006; Swartz 2005; VanDorn 2006). However, an analy-
sis of the content of PADs developed by 106 outpatients in the US
(Srebnik 2005) showed that in 95% of cases the PADs were rated
as clinically useful and consistent with clinical practice standards.
Another type of advance statement, the Wellness Recovery Ac-
tion Plan (WRAP) is a structured self-management intervention
that assists users both manage symptoms and consider broader life
issues. A recent assessment of WRAPs for mental illness (Cook
2009) suggests that it may generate improvements in a range of
areas including symptoms, hopefulness and feelings of empow-
erment. Furthermore, a case series study of the Joint Crisis Plan
intervention (Sutherby 1999) in which patients develop their per-
sonalised plan for use in a crisis or possible relapse, suggests that
hospital use may be reduced in those who develop such a plan. The
increased input in determining future treatment was suggested to
be an important factor in determining the perceived coerciveness
of the treatment experience (Lidz 1995). It certainly seems plausi-
ble that those who have little knowledge of the patient or no access
to their notes, such as a junior psychiatrist in a hospital emergency
department, would find such information useful in making an ap-
propriate disposition, and further that actions carried out which
have been previously negotiated are less likely to require compul-
sory interventions.
Description of the condition
For the purpose of this review, we defined severe mental illness
(SMI) as psychotic disorders and severe mood disorders such as
bipolar disorder and depression with psychotic features. Psychosis
is a collective term used to describe a range of conditions includ-
ing schizophrenia, delusional disorder, and schizoaffective disor-
der. Individuals with psychotic disorders may experience a range
of symptoms including unusual thoughts or ’delusions’, hallucina-
tions, and mood disturbance such as emotional flatness and with-
drawal. Recent studies of schizophrenia globally suggest that about
seven individuals per 1000 will be affected and individuals with
schizophrenia have a two to threefold increased risk of dying com-
pared to the general population (McGrath 2008). The economic
burden associated with schizophrenia is substantial, with recent
estimates suggesting it represents between 1.5% and 3% of total
healthcare expenditures (Knapp 2004).
Description of the intervention
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’User-held records’ may be defined as information, held by the
individual with the illness, which contains all or some personal
information relating to the course and care of his or her illness.
User-held records may include notes made by professionals at ap-
pointments and kept by the patient, advance directives and crisis
cards (personal information held for use in the event of a crisis or
relapse).
How the intervention might work
The main aim of providing individual patients with personalised
information about their illness and treatment is to improve the in-
dividual’s sense of control and empowerment. Providing patients
with information is thought to increase their feelings of involve-
ment in their treatment, reducing the perceived coerciveness of
the treatment experience (Lidz 1995); it may also facilitate early
help-seeking.
Why it is important to do this review
This is an update of a Cochrane review first published in 1999
(Henderson 1999). The previous review found no studies meet-
ing the criteria for inclusion, but found two ongoing trials (Lester
2003; Papageorgiou 2002). Since the publication of the original
Cochrane review, there have been a number of published and rele-
vant clinical trials undertaken. Additionally, current national treat-
ment guidelines in the United Kingdom (NICE 2009) recom-
mend involvingmental health service users in decisions about their
treatment and providing opportunities for service users to make
advance statements and advance decisions to refuse treatment.
Valid advance decisions are now legally binding under the UK’s
Mental Capacity Act 2005.User-held records potentially provide a
cost-effective methodology for facilitating such involvement. Sev-
eral of the authors of this updated review are affiliated with an on-
going trial of user-held records (CRIMSON) (Thornicroft 2010).
Another randomised evaluation of user-held records for those with
serious mental illnesses (Ruchlewska 2009) is known to be ongo-
ing.
O B J E C T I V E S
To evaluate the effects of personalised, accessible, user-held clinical
information for people with a severe mental illness (defined as
psychotic illnesses).
M E T H O D S
Criteria for considering studies for this review
Types of studies
All relevant randomised, controlled trials (RCTs).
Types of participants
Adults with SMI. For the purposes of the review we defined SMI
as a diagnosis of a psychotic illness, including other psychoses
such as bipolar disorder and depression with psychotic features. In
studies where there was a mixture of diagnostic groups, only those
studies where themajority of participants (that is, more than 50%)
had psychotic diagnosis were included.We did not include studies
where the sole diagnosis was bipolar disorder or depression. People
whose main problem and primary diagnosis was one of deliberate
self harm were also not the focus of this review.
Types of interventions
1. User-held information: any personalised and accessible
clinical information held by the patient beyond standard
care.
This includes both user-held records (notes made by professionals
at appointments and kept by the patient) and crisis cards (per-
sonal information held for use in the event of a crisis or relapse).
Generic information on diagnosis, treatment or services available
was excluded.
2. Standard information: any information routinely held such
as appointment cards and generic information on diagnosis,
treatment or services available.
In certain settings standard information may include a copy of
the treatment plan with contact details for the key carers (DoH
1990).
Types of outcome measures
Outcomes were not part of the criteria for including studies in the
review.Outcomes of interest are listed below.Wedivided outcomes
into very short term (less than three months), short term (less than
six months), medium term (seven to 12 months) and long term
(over one year).
Primary outcomes
1. Psychiatric hospital admission
1.1 Admitted or not
1.2 Compulsory admission
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1.3 Number of days spent in hospital
1.4 Discharged or not
2. Death from causes other than suicide
3. Violence
3.1 To self
3.1.1 Non-fatal
3.1.2 Fatal
3.2 To others
3.2.1 Major (homicide, sex attacks, attempted or actual serious
assault)
3.2.2 Non-major (incidents requiring attendance of police or on-
ward seclusion or special civil law admissions to a place of safety)
Secondary outcomes
1. Rates of criminal charges
2. Mental state
2.1 Relapse of psychotic illness
2.2 Mental state score
3. Satisfaction with health care
3.1. Patient satisfaction
3.2. Carer satisfaction
4. Perceived coercion on hospital admission
5. Acceptability of management
5.1 As measured by loss to follow-up within the study
6. Compliance with treatment other than the intervention
7. Social functioning
7.1 Homelessness
7.2 Employment
7.3 Average change in social functioning
8. Economic costs of all care and health care
9. Other relevant measures
10. Summary of findings table
Weused theGRADEapproach to interpret findings (Schünemann
2008) and used the GRADE profiler (GRADEPRO) to import
data from RevMan 5.1 (Review Manager) to create ’Summary of
findings’ tables. These tables provided outcome-specific informa-
tion concerning the overall quality of evidence from each included
study in the comparison, the magnitude of effect of the interven-
tions examined, and the sum of available data on all outcomes
we rated as important to patient care and decision making. We
aimed to select the following main outcomes for inclusion in the
’Summary of findings’ table.
• Psychiatric hospital admission: general admission - medium
and long term
• Psychiatric hospital admissions: compulsory admission -
medium and long term
• Death: causes other than suicide
• Violence
• Mental state: psychopathology - medium and long term
• Satisfaction with health care - medium and long term
Search methods for identification of studies
Electronic searches
We searched the Cochrane Schizophrenia Group Trials Register
(August 2011) using the phrase:
[((*consumer?h?ld* or *consumer?particip* or *client?h?ld* or
*client?particip* or *user?h?ld* or *user?particip? or *patient?h?ld*
or *patient particip* or (*Cris?s* AND *plan*) in the title, ab-
stract and index terms in REFERENCE) and ((patient particip*
or patient info* or *decision* or medical record* or *crisis plan*)
in interventions field in STUDY)]
This register is compiled by systematic searches ofmajor databases,
handsearches of journals and conference proceedings (see Group
Module). For previous searches please see Appendix 1.
Searching other resources
1. Reference lists
All references of included articles were searched for further relevant
trials.
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Data collection and analysis
Methods used in data collection and analysis for this update are
below, for previous methods please see Appendix 2.
Selection of studies
SF and GB independently inspected all citations from the searches
and identified relevant abstracts. Where disputes arose, the full
report was acquired for more detailed scrutiny and was indepen-
dently assessed. All included citations were then discussed with
CH. Where it was not possible to resolve a disagreement by dis-
cussion, we contacted the authors of the study for clarification.
If citations met the inclusion criteria, we obtained full reports of
the papers for more detailed inspection. Full reports were then
inspected by SF and GB, and discussed with CH.
Data extraction and management
1. Extraction
Review author SF extracted data from all included studies. In ad-
dition, to ensure reliability, GB independently extracted data from
all studies. Any disagreement was discussed with CF (statistician)
and the decisions documented and, if necessary, authors of stud-
ies were contacted for clarification. CH provided advice and fi-
nal decisions were documented. We attempted to contact authors
through an open-ended request in order to obtain missing in-
formation or for clarification whenever necessary. If studies were
multi-centre, where possible, we extracted data relevant to each
component centre separately.
2. Management
2.1 Forms
We extracted data onto standard, simple forms.
2.2 Scale-derived data
We included continuous data from rating scales only if:
a. the psychometric properties of the measuring instrument have
been described in a peer-reviewed journal (Marshall 2000); and
b. the measuring instrument has not been written or modified by
one of the trialists for that particular trial.
Ideally the measuring instrument should either be: i. a self-report,
or ii. completed by an independent rater or relative (for example,
not the therapist). We acknowledge that this is often not reported
clearly and noted if this was the case or not in the ’Description of
studies’ section.
2.3 Endpoint versus change data
There are advantages of both endpoint and change data. Change
data can remove a component of between-person variability from
the analysis.On the other hand the calculationof change needs two
assessments (baseline and endpoint), which can be problematic in
unstable and difficult tomeasure conditions such as schizophrenia.
We decided to primarily use endpoint data, and only use change
data if the former were not available. If we had found both, we
would have combined endpoint and change data in the analysis
and used mean differences (MD) rather than standardised mean
differences throughout (Higgins 2011).
2.4 Skewed data
Many of our targeted outcomes tend to be skewed, for example,
duration of admission and duration of compulsory admission. For
this reason the authors of included studies have provided non-
parametric summary measures and tests, that is, the median and
range, and tested with the Mann-Whitney U test. Since it is not
possible to combine non-parametric data in a meta-analysis, and
there were so few studies that met the inclusion criteria and pro-
vided these data, we report these data in ’Other data’ tables.
2.5 Common measure
To facilitate comparison between trials, we converted variables re-
ported in differentmetrics, such as days in hospital (mean days per
year, per week or per month), to a common metric (for example,
mean days per month).
2.6 Conversion of continuous to binary
Where possible we tried tomaintain continuous measures to avoid
losing information and power in the analyses.
2.7 Direction of graphs
Where possible, we entered data in such a way that the area to
the left of the line of no effect indicated a favourable outcome
for user-held records. Where keeping to this made it impossible
to avoid outcome titles with clumsy double-negatives we reported
data where the left of the line indicates an unfavourable outcome.
This was noted in the relevant graphs.
Assessment of risk of bias in included studies
SF and GB worked independently to assess risk of bias by using
the criteria described in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011) to assess trial quality. This
set of criteria is based on evidence of associations between overes-
timation of effect and high risk of bias of the article, such as se-
quence generation, allocation concealment, blinding, incomplete
outcome data and selective reporting.
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If the raters disagreed, the final rating was made by consensus,
with advice from CH.Where inadequate details of randomisation
and other characteristics of trials were provided, the authors of
the studies were contacted in order to obtain further information.
Non-concurrence in quality assessment was reported, but if dis-
putes arose as to which category a trial was to be allocated, again,
resolution was be made by discussion.
Measures of treatment effect
1. Binary data
For binary outcomeswe calculated a standard estimationof the risk
ratio (RR) and its 95% confidence interval (CI). It has been shown
that RR is more intuitive (Boissel 1999) than odds ratios and that
odds ratios tend tobe interpreted asRRby clinicians (Deeks 2000).
For statistically significant results we had planned to calculate the
number needed to treat to provide benefit/to induce harm statistic
(NNTB/H), and its 95% confidence interval (CI) using Visual
Rx (http://www.nntonline.net/) taking account of the event rate
in the control group. This, however, has been superseded by the
Summary of findings for the main comparison and calculations
therein.
2. Continuous data
Wehad too few studies to combine continuous outcomes. Further-
more, outcomes common to more than one study were assessed
by different measures therefore precluding any combined estimate
of effect. However, if we had found sufficient studies we would
have estimated the mean difference (MD) between groups. Data
from included studies were often skewed, in these circumstances
we have presented the data as reported by the original authors in
’Other data’ tables.
Unit of analysis issues
1. Cluster trials
Studies increasingly employ ’cluster randomisation’ (such as ran-
domisation by clinician or practice) but analysis and pooling of
clustered data poses problems. Firstly, authors often fail to account
for intra-class correlation in clustered studies, leading to a ’unit
of analysis’ error (Divine 1992) whereby P values are spuriously
low, confidence intervals unduly narrow and statistical significance
overestimated. This causes type I errors (Bland 1997; Gulliford
1999).
For relevant cluster trials that did not account for clustering in
the primary studies (Warner 2000), we have presented data in
a table marked with a (*) symbol to indicate the presence of a
probable unit of analysis error. We have sought statistical advice
and were advised that the binary data as presented in a report
should be divided by a ’design effect’. This is calculated using the
mean number of participants per cluster (m) and the intra-class
correlation coefficient (ICC) (design effect = 1 + (m - 1)*ICC)
(Donner 2002). If the ICC was not reported it was assumed to be
0.1 (Ukoumunne 1999).
Clustering was appropriately incorporated into the analysis of one
of the cluster studies (Lester 2003) but not in the second (Warner
2000). Therefore we have reported the original data as if from
a non-cluster randomised study (Analysis 1.1) and, in addition,
have provided a cluster-adjusted outcome where frequencies have
been divided by the design effect (Analysis 1.8).
2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It
occurs if an effect (for example, pharmacological, physiological or
psychological) of the treatment in the first phase is carried over to
the second phase. As a consequence, on entry to the second phase
the participants can differ systematically from their initial state
despite a wash-out phase. For the same reason cross-over trials are
not appropriate if the condition of interest is unstable (Elbourne
2002). We did not find any cross-over trials in our search.
3. Studies with multiple treatment groups
We did not find any multiple treatment group studies, but we
would have presented the additional treatment arms in compar-
isons. If data were binary we would have added and combined
the data within the two-by-two table. If data were continuous
we would have combined data following the formula in section
7.7.3.8 (Combining groups) of the Cochrane Handbook for Sys-
tematic Reviews of Interventions. Where the additional treatment
arms were not relevant, we would not have reproduced these data.
Dealing with missing data
1. Overall loss of credibility
At some degree of loss of follow-up data must lose credibility (Xia
2009). We chose that, for any particular outcome, should more
than 50% of data be unaccounted for we would not reproduce
these data or use them within analyses. If, however, more than
50% of those in one arm of a study were lost, but the total loss
was less than 50%, we would have marked such data with (*) to
indicate that such a result may well be prone to bias. However,
this did not occur for any of the included studies.
2. Binary
The included studies had low attrition on the primary outcomes.
However, had we found higher attrition rates we would have fol-
lowed the following procedure. Where attrition for a binary out-
come was between 0% and 50% and where these data were not
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clearly described, we would have presented data on a ’once ran-
domised always analyse’ basis (an intention-to-treat analysis). We
would have assumed that data were missing at random, and that
those leaving the study early would be similar to those remaining
and have the same rates of negative outcome as those who com-
pleted the study.
3. Continuous
3.1 Attrition
If attrition for a continuous outcome had been between 0% and
50% and completer-only data were reported, we would have re-
produced these. However, this was not the case.
3.2 Standard deviations
The continuous outcomemeasures in our studies were skewed and
authors reported the median as a summary measure rather than
the mean. In the case of skewed data the standard deviation is not
a useful measure and so we did not seek to obtain it. Had themean
values been reported but not the standard deviations we would
have first tried to obtain the missing values from the authors. If
not available, we would have calculated the standard deviation,
where possible, from the data provided, that is, from confidence
intervals and statistical tests.
3.3 Last observation carried forward
We did not find any studies that used the last observation carried
forward (LOCF) for missing data. If this had been used in a trial
for less than 50% of the data, we would have reproduced these data
and indicated that they were the product of LOCF assumptions.
Assessment of heterogeneity
1. Clinical heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge clinical heterogeneity. We simply inspected
all studies for clearly outlying people or situations which we had
not predicted would arise. When such situations or participant
groups arose, these were discussed.
2. Methodological heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge methodological heterogeneity. We simply
inspected all studies for clearly outlyingmethodswhichwe had not
predicted would arise. When such methodological outliers arose
these were fully discussed.
3. Statistical heterogeneity
3.1 Visual inspection
We visually inspected graphs to investigate the possibility of sta-
tistical heterogeneity.
3.2 Employing the I2 statistic
Heterogeneity between studies was investigated by considering the
I2 statistic method alongside the Chi2 P value. The I2 provides
an estimate of the percentage of total variance due to study het-
erogeneity (beyond inconsistency thought to be due to chance)
(Higgins 2003). The importance of the observed value of I2 de-
pends on: i. magnitude and direction of effects, and ii. strength of
evidence for heterogeneity (for example, P value fromChi2 test, or
a confidence interval for I2). An I2 estimate greater than or equal
to around 50%, accompanied by a statistically significant Chi2
statistic, was interpreted as evidence of substantial levels of hetero-
geneity (Higgins 2011). When substantial levels of heterogeneity
were found in the primary outcome, we explored reasons for het-
erogeneity (Subgroup analysis and investigation of heterogeneity).
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997).
These are described in Section 10 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We are aware
that funnel plots may be useful in investigating reporting biases
but are of limited power to detect small-study effects. As we had
less than 10 studies, we did not use funnel plots.
Data synthesis
We understand that there is no closed argument for preference for
use of fixed-effect or random-effects models. The random-effects
method incorporates an assumption that the different studies are
estimating different, yet related, intervention effects. This often
seems to be true to us and the random-effects model takes into
account differences between studies even if there is no statistically
significant heterogeneity. There is, however, a disadvantage to the
random-effects model. It adds an extra weight to all studies, mak-
ing the weights more evenly spread and giving small studies rel-
atively more weight compared to the fixed-effect model analysis.
The small studies are often the most biased ones and, depending
on the direction of effect, these studies can either inflate or deflate
the effect size. We chose the random-effects model for all analyses
as the studies were all of similar size. The reader is, however, able
to choose to inspect the data using the fixed-effect method.
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Subgroup analysis and investigation of heterogeneity
1. Subgroup analyses - only primary outcomes
We proposed to undertake this review and provide an overview of
the effects of user-held records for people with schizophrenia, and
therefore we did not perform any subgroup analyses.
2. Investigation of heterogeneity
If inconsistency was high, this was reported. First we investigated
whether the data had been entered correctly. Second, if data were
correct, the graph was visually inspected and studies outside the
company of the rest were successively removed to see if homogene-
ity was restored. For this review we decided that should this occur
with data contributing to the summary finding of no more than
around 10% of the total weighting, the data were presented. If
not, the data were not pooled and issues were discussed. We know
of no supporting research for this 10% cut off but are investigating
use of prediction intervals as an alternative to this unsatisfactory
state.
When unanticipated clinical or methodological heterogeneity was
obvious, we simply stated that hypotheses regarding these for fu-
ture reviews or versions of this review would be generated. We did
not undertake analyses relating to these.
Sensitivity analysis
1. Implication of randomisation
We planned to include trials in a sensitivity analysis if they were
described in some way as to imply randomisation. For the primary
outcomes we included these studies and if there was no substantive
difference when the implied randomised studies were added to
those with a better description of randomisation, then all data were
employed from these studies.
2. Assumptions for lost binary data
There was low attrition in the included studies and therefore it
was not necessary to perform a sensitivity analysis.
3. Risk of bias
We analysed the effects of excluding trials that were judged to be
at high risk of bias across one or more of the domains of randomi-
sation (implied as randomised with no further details available),
allocation concealment, blinding and outcome reporting for the
meta-analysis of the primary outcome. If the exclusion of trials at
high risk of bias did not substantially alter the direction of effect
or the precision of the effect estimates, then data from these trials
were included in the analysis.
4. Imputed values
We also undertook a sensitivity analysis to assess the effects of
including data from trials where we used imputed values for ICC
in calculating the design effect in cluster randomised trials.
If substantial differences were noted in the direction or precision
of effect estimates in any of the sensitivity analyses listed above,
we did not pool data from the excluded trials with the other trials
contributing to the outcome but presented them separately.
5. Fixed and random effects
We assessed the differences between using a fixed-effect model and
a random-effects model on our primary outcomes of interest.
R E S U L T S
Description of studies
Results of the search
Electronic searches identified 237 references. Seventy-five poten-
tially relevant records were obtained and scrutinised, and 70 of
these reports did notmeet the inclusion criteria (see Characteristics
of excluded studies). Two references were protocols for ongoing
trials for which no data were available at the time of review (Figure
1).
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Figure 1. Study flow diagram.
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Included studies
Four studies met our inclusion criteria (Henderson 2004; Lester
2003; Papageorgiou 2002; Warner 2000) and are summarised in
the ’Characteristics of included studies’ table. One study met our
inclusion criteria, however we were unable to include it as the
required summary statistics and results were not provided in the
report. We have classified this study (Swanson 2006) as ’awaiting
classification’ in the event we should obtain the relevant results
from the study authors in the future.
1. Study design
All studies were randomised controlled trials. Warner 2000 and
Lester 2003 used cluster randomisation and the remaining trials
used individual level randomisation. Both cluster trials acknowl-
edged and investigated clustering effectswithin their reported data.
The Lester 2003 study reported that the random-effects model
did not alter the results of their analysis and so reported the orig-
inal figures, which we use in our report. The Warner 2000 study
did not specifically report a cluster-adjusted analysis, but provided
a design effect based on the intra-class correlation coefficient of
1.53. We have reported the results with the original data and have
additionally provided a cluster-adjusted result where the Warner
2000 frequencies have been divided by the design effect.
2. Study sizes
The total number of participants included in the four studies was
N = 607. The average among the studies was n = 152 and the
range was 90 to 201.
3. Study setting
All studies were conducted in the United Kingdom. Warner 2000
and Lester 2003 were conducted in a ’shared care’ setting, that
is, care that was jointly provided by primary and secondary care.
Lester 2003 was conducted between six community mental health
teams in Birmingham (UK); Papageorgiou 2002 was delivered
in an inpatient setting, whereas all other trials involved partic-
ipants who were treated in community settings. Participants in
Henderson 2004 were from eight community mental health teams
in South London and Kent (UK).
4. Participants
With the exception of Lester 2003, which included only those peo-
ple with a diagnosis of schizophrenia, all studies had a mixture of
diagnoses. Henderson 2004 recruited individuals with psychosis
and bipolar disorders (proportions not reported). Papageorgiou
2002 had 63%with psychosis and 28%with depression and bipo-
lar.Warner 2000 had 42% schizophrenia and 12% bipolar (the re-
maining diagnoses included 22% depression and 14% ’other’) and
thereby reached our inclusion criterion (at least 50%). In terms of
gender profile, there were 338 male participants and 269 female
participants across the studies, with the studies having a majority
male sample (range 53% to 68%). The average age in the studies
was very similar, with inclusion criteria ranging from 18 to 66
years, and a mean age of 39 years.
5. Interventions
Two of the studies (Henderson 2004; Papageorgiou 2002) tested
a form of advance statement (Henderson 2008); that is, personal
information and treatment preferences held for use in the event
of a crisis or relapse. In these two studies, the user developed
the user-held record with the help of a researcher or ’facilitator’,
and in the Henderson 2004 study the clinical team involved in
delivering routine care was also involved. The content of these
interventions was similar and broadly included the users’ views on
relapse indicators, wishes for future treatment, contact details for
themselves, their clinicians and family and carers. They may also
have included an indication of treatments that they did not want,
that is, a refusal of medication.
The other two studies (Lester 2003; Warner 2000) tested a form
of medical record which included aspects such as contact details,
clinical notes, future appointments and medication. Lester 2003
also included an indicationof relapse indicators and a diary section.
For Lester 2003 and Warner 2000, these records were given to the
user after randomisation.
All studies compared the active intervention to ’treatment as
usual’ in primary or secondary care. In addition, Henderson 2004
provided control participants with information leaflets regard-
ing local services, treatments, and relevant legislation and policies
(Henderson 2004).
6. Outcomes (rating scales)
A range of outcomes were investigated in the included studies.
However, only four outcomes were investigated by more than one
study: psychiatric hospital admissions; psychopathology; satisfac-
tion; and outpatient attendance. All outcomes investigated by the
studies are listed below.
6.1 Psychiatric admissions
Each included study compared the effect of user-held records to
treatment as usual on the rate and length of psychiatric admission.
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6.2 Compulsory psychiatric admissions
Henderson 2004, Lester 2003 and Papageorgiou 2002 also exam-
ined the rates of compulsory psychiatric hospital admissions under
a section of the UK’s Mental Health Act. Henderson 2004 and
Papageorgiou 2002 additionally looked at number of days spent
under a section of the Mental Health Act.
6.3 Psychopathology
Psychopathology was examined by three of the four studies (Lester
2003; Papageorgiou 2002; Warner 2000).
6.3.1 Brief Psychiatric Rating Scale (BPRS) (Overall 1962)
Warner 2000 used the BPRS, which is a rating scale designed to
assess psychopathology across 16 dimensions: somatic concern;
anxiety; emotional withdrawal; conceptual disorganisation; guilt
feelings; tension; mannerisms and posturing; grandiosity; depres-
sive mood; hostility; suspiciousness; hallucinatory behaviour; mo-
tor retardation; uncooperativeness; unusual thought content; and
blunted affect. The BPRS is usually rated by an experienced re-
searcher or clinician, with each item rated on a seven-point scale,
varying from 0 = ’not present’ to 7 = ’extremely severe’, with high
scores indicating more severe symptoms.
6.3.2 Behavior and Symptom Identification Scale (BASIS-32) (Eisen
1994)
Papageorgiou 2002 and Warner 2000 used the BASIS-32 scale,
which is a self-report measure completed by patients. The BASIS-
32 has five subscales: relation to self and others; daily living and
role functioning; depression and anxiety; impulsive and addictive
behaviour; and psychosis. Thirty-two items are rated between 0
(= no problem) and 4 (= severe problem).
6.3.3 Krawiecka and Goldberg (K & G) scale (Krawiecka 1977)
Additionally, Lester 2003 used the K & G scale, which is a five-
point rating scale assessing psychopathology across the follow-
ing domains: depressed; anxious; coherently expressed delusions;
hallucinations; incoherence and irrelevance of speech; poverty of
speech; flattened incongruous affect; psychomotor agitation; and
side effects of medication (tremor, rigidity, dystonic reactions,
akathisia, difficulties with vision, other). A score of 0 represents
the absence of an item, where a score of 4 may indicate severe
psychopathology.
6.4 Satisfaction
6.4.1 Verona Service Satisfaction Scale (VSSS) (Ruggieri 1993)
Three studies examined the effect of the intervention on patient
satisfaction. Lester 2003 and Papageorgiou 2002 used the Verona
Service Satisfaction Scale (VSSS), however Papageorgiou 2002
used an ’adapted brief version’. The full VSSS-54 contains 54
items rating questions over seven dimensions: overall aspects; pro-
fessionals’ skills and behaviour; information; access; efficacy; types
of intervention; and relative’s involvement. This is a five-point
Likert scale, with a score of 1 = ’terrible’ and 5 = ’excellent’.
6.4.2 Client Satisfaction Questionnaire (CSQ) (Larsen 1979)
Warner 2000 used the Client Satisfaction Questionnaire (CSQ),
which is an eight-item self-report measure covering: quality of
service; needs addressed; amount of assistance; effect of assistance;
recommendable; and overall satisfaction. Each item is rated on a
one to four scale, with a lower score indicating a worse outcome.
6.5 Outpatient visits
Lester 2003 and Warner 2000 both examined outpatient visits in
terms of attendance.
6.6 Economic costs
TheHenderson 2004 study published a secondary economic eval-
uation paper comparing the costs of service use between those
who received the intervention and the control group over the 15-
month study period. They used a modified version of the client
service receipt inventory to collect information about use of ser-
vices. Hospital use was collected from patient medical records and
the Mental Health Act office.
6.7 Other outcomes
Several other outcomes were investigated by individual studies
including: self efficacy (no summary statistics so unable to include)
(Papageorgiou 2002); and use of home treatment and non-mental
health referrals (Lester 2003).
Excluded studies
Of the 75 potentially relevant references identified in the updated
search, 17 were duplicate studies or secondary references, and 49
were excluded as they did not meet the inclusion criteria described
in the ’Types of studies’, ‘Types of participants’, and ‘Types of in-
terventions’. The most common reason for exclusion was that the
intervention did not involve a user-held information component.
Four further references were excluded after contacting the authors
(n = 3) or having materials translated (n = 1). Hamann 2006 was a
trial of shared decision making compared with standard treatment
for 113 individuals with psychotic disorders treated in an inpatient
setting in Germany. The intervention involved patients working
through a decision aid booklet and noting their preferences for
care, and using that as a prompt for discussion with their treat-
ing doctor; however, the patients did not hold the a record after
this consultation. Similarly, Van Os 2004 examined the effect of
patients completing a checklist (2-COM) to identify care needs
prior to routine consultations with their doctor, however the pa-
tients did not hold a record of the consultation or treatment plan.
Likewise, Borell 1995 examined a psycho-education initiative that
involved some personalised information, but the patients did not
hold the records after the sessions. Finally, Swanson 2008 was ex-
cluded as it was a secondary paper from the Swanson 2006 study
15User-held personalised information for routine care of people with severe mental illness (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
that examined coercive events within the intervention group who
received a Facilitated Psychiatric Advance Directive, that is, there
was no comparison group.
Previously excluded studies are discussed below and reasons for
exclusion are listed in the ’Characteristics of excluded studies’ table.
Stafford 1997 was an audit of 45 people with long term mental
illness who agreed to carry a small pocket-sized file containing
contact details, early warning signs for relapse, and notes made by
professionals. Level of use was recorded by checking entries in the
professionals’ notes against those in the record, and the holders
were surveyed on their views of the usefulness of the record as
a whole and of its separate components. There was no control
group. Two randomised studies concerned the use of ’green cards’
to facilitate access to services for patients with a primary diagnosis
of deliberate self harm (Cotgrove 1995;Morgan 1993) rather than
one of a psychotic illness. Six other studies were already known
of by the authors but were not identified by the search strategy.
The aims of three (Essex 1990; Pickersgill 1998; Wolf 1996) were
to improve shared care between professional primary care givers
and specialist mental health services as well as to empower users
of mental health services (Essex 1990; Reuler 1991; Wolf 1996).
Pickersgill 1998 primarily focused on patient empowerment along
with developing partnerships with users and carers. Each of these
uncontrolled studies described the development and introduction
of a personal record and then surveyed the individuals’ views on
its usefulness or level of use. (Sutherby 1999) described the use
of crisis cards and joint crisis plans for people with severe mental
illnesses who were in receipt of specialist care. ’Joint crisis plans’
were drawn up once the contents had been agreed by both the
team and patient at a meeting between the patient, an advocate if
required, team members and a facilitator. Where the team could
not agree with the patient’s wishes, these were to have been written
on a ’crisis card’ instead. Participants were then followed up and
asked their views on the plans and whether they had affected how
they felt about their illness and treatment. There was no control
group. The last case series (Backlar 1996) was not an intervention
study but a postal survey of members of organisations for relatives
of mentally ill people, to assess the level of use of advance directives
for mental health treatment.
Ongoing
Two ongoing studies were found (Ruchlewska 2009; Thornicroft
2010) and are summarised in the ’Characteristics of ongoing
studies’ table. Both trials were due to be completed at the end of
2011 and were expected to report results in 2013.
Awaiting assessment
Swanson 2006 did not report any summary statistics of potentially
relevant outcomes. We were unable to obtain further data from
the authors.
Risk of bias in included studies
For summary and graphical representation of the risk of bias please
see Figure 2 and Figure 3.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Full assessment of bias was hindered by inadequate reporting in
some of the trials. Authors were contacted for further information
but either relevant data were not available or we received no reply
from the requests for further information.
Allocation
All trials were randomised, and each provided a detailed descrip-
tion of methods used to reduce problems associated with alloca-
tion (Henderson 2004; Lester 2003; Papageorgiou 2002; Warner
2000).
Blinding
Due to the nature of the intervention, none of the trialswere able to
use double-blinding procedures. However, three trials (Henderson
2004; Lester 2003; Papageorgiou 2002) attempted to reduce bias
by using outcome raters who were blinded to allocation. The re-
maining study (Warner 2000) did not report on the blinding of
outcome raters.
Incomplete outcome data
One study (Warner 2000) did not report missing data in sufficient
detail and was therefore rated as unclear risk. The remaining stud-
ies (Henderson 2004; Lester 2003; Papageorgiou 2002) attempted
to reduce bias by using outcome raters who were blinded to allo-
cation. The remaining studies had low levels of data attrition, and
where present it was spread evenly across the intervention arms.
Reasons for data attrition were considered unlikely to be a result
of the intervention.
Selective reporting
All data in this review came from the published reports of the
trials. None of the studies had published protocols and therefore
we were unable to determine if the published report covered the
full range of planned comparisons.
Other potential sources of bias
We detected no other potential sources of bias.
Effects of interventions
See: Summary of findings for the main comparison User-held
information versus standard information for routine care of people
with severe mental illness
Comparison 1: user-held records versus treatment as
usual
All pooled data are presented below. For continuous outcomes,
where means and standard deviations were unavailable these have
been presented in the ’Other data’ tables as ’unpooled secondary
outcomes’, including data that was not suitable for data synthesis.
1.1 Psychiatric hospital admission
Many of the results were not provided as means and standard
deviations. We have, however, presented results in our data and
analysis section where other data such as medians or ranges were
reported.
1.1.1 Psychiatric admission
Psychiatric hospital admission data were available for four trials
involving 597 participants. We found no significant effect of the
intervention in any of these studies individually. The pooled treat-
ment effect showed no significant impact of the intervention and
was of very low magnitude (n = 597, 4 RCTs, RR 0.99 CI 0.71
to 1.38, Analysis 1.1), see Figure 4 and Summary of findings for
the main comparison. There was some heterogeneity between the
studies (P = 0.16; I2 = 41%), with the variance explained by be-
tween-study differences.
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Figure 4. Forest plot of comparison: 1. Psychiatric hospital admission: 1. general admission.
We adjusted the cluster randomised study for the design effect but
found very little effect on the pooled effect estimate (n = 566, 4
RCTs, RR 0.97 CI 0.70 to 1.35, Analysis 1.8).
1.1.2 Compulsory admission
Only three studies involving 507 participants provided informa-
tion on compulsory admissions to hospital. This is a low number
of studies for a meta-analysis, though we have provided a pooled
estimate (see Figure 5). When pooled there was no significant
effect of the intervention (n = 507, RR 0.64 CI 0.37 to 1.10,
Analysis 1.1). Heterogeneity was lower in this comparison (P =
0.28; I2 = 21%), though this was very difficult to judge with only
three studies considered (see Summary of findings for the main
comparison).
1.1.3 Psychiatric admission - number of days spent in
hospital
Summary data on the length of admissions were provided by three
studies, none of which found a significant impact of the inter-
vention. It was not possible to pool this data as the measure was
skewed and so non-parametric summary measures were provided
(Analysis 1.3). There was evidence of some heterogeneity between
the studies in terms of the median length of admissions, and the
magnitude and direction of the treatment effect. This would sug-
gest that the studies were not comparable on this outcome.
1.1.5 Compulsory admission - number of days spent in
hospital under a section of the Mental Health Act
Two trials also provided information on length of compulsory ad-
mission (that is, days under a section of theMental Health Act). A
significant effect of the intervention was stated to have been found
in one study but not the other (Analysis 1.3); the results gener-
ally suggested that people who received user-held personal infor-
mation spent less time in hospital under compulsory admission.
It was not possible to pool this data as the measure was heavily
skewed and so non-parametric summary measures were provided.
These data should be interpreted with caution.
1.2 Mental state
1.2.1 Psychopathology
Psychopathology was examined, using three differentmeasures, by
three of the four studies (Lester 2003; Papageorgiou 2002;Warner
2000).
1.2.1.1 Brief Psychiatric Rating Scale (BPRS), high = worse,
skew
The one study that reported this outcome found little effect of the
user-held information on psychopathology using the BPRS scale.
These data were not included in a meta-analysis due to the large
standard deviations, and they were considered skewed. These are
best inspected by viewing Analysis 1.4.
1.2.1.2 Behaviour and Symptom Identification Scale-32
(BASIS-32), high = worse, skew
Two trials used the self-report measure of BASIS-32. The
Papageorgiou 2002 study presented only the data as median and
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range, with heavily skewed data, which are therefore presented in
additional Table 5. In the Warner 2000 study, there was no effect
of the intervention on self-reported psychopathology measured by
the BASIS-32; however these data were also heavily skewed and
are included in a separate table (Analysis 1.4).
1.2.1.3 Krawiecka and Goldberg (K & G), high = worse, skew
Lester 2003 reported change scores using the K & G scale rated
by blinded keyworkers; there was no effect of the intervention.
Because the standard deviations were large, the data were reported
separately (Analysis 1.4).
1.3 Satisfaction
The three studies (Lester 2003; Papageorgiou 2002;Warner 2000)
examining satisfaction found no effect.
1.3.1 Client Satisfaction Questionnaire (CSQ), high = better,
skew
One small study used theCSQ and found no effect of intervention
(1 RCT, n = 90, MD -0.89 CI -3.35 to 1.15). When entered
into data synthesis, the calculated mean difference was different
than that reported in the published report. We decided to use the
published data and present this in an additional table (Analysis
1.5).
1.3.2 Verona Hospital Service Satisfaction Scale (VSSS), high
= better, skew
As above, the data in one study were either skewed or adjusted; we
therefore presented these data as reported by the authors in Table
7. Lester 2003 reported change scores on the VSSS scale; there was
no effect of the intervention (Analysis 1.5). Using a brief version
of the VSSS, Papageorgiou 2002 reported no effect (Analysis 1.5).
1.4 Other relevant measures
1.4.1 Service use
1.4.1.1 Outpatient attendance
Lester 2003 and Warner 2000 both examined the effect of user-
held records on outpatient attendance and found no effect (2
RCTs, n = 281, RR 1.09 CI 0.92 to 1.29, Analysis 1.6).
1.4.1.2 Home treatment use
Lester 2003 examined the use of home treatment teams, and
demonstrated no difference (n = 191, 1 RCT, RR 0.72 CI 0.21 to
2.46, Analysis 1.6).
1.4.1.3 Non-mental health referrals
Lester 2003 also examined the use of non-mental health referrals,
which again demonstrated no difference (n = 191, 1 RCT, RR
1.08 CI 0.59 to 1.98, Analysis 1.6).
1.5 Economic costs of care
1.5.1 Client service receipt inventory (cost, skew)
A secondary economic analysis (Flood 2006) of the Henderson
2004 trial suggested that while the mean difference in costs be-
tween user-held records and treatment as usual was not signifi-
cantly different, the user-held personal information intervention
(JCP) was more likely than not to be cost effective, most likely
due to the reduction in compulsory admissions in the intervention
group. However, due to very large standard deviations and skewed
data, these results were presented in a separate table (Analysis 1.7).
Sensitivity analysis
1. Implication of randomisation
There were no studies that implied randomisation; all included
studies provided details as to randomisation.
2. Assumptions for lost binary data
There was low attrition in the included studies and therefore it
was not necessary to perform a sensitivity analysis.
3. Risk of bias
No studies were rated as at ’high’ risk across one or more of the
domains of risk of bias, therefore a sensitivity analysis was not
necessary.
4. Imputed values
Adjusting for the reported ICC in the cluster randomised trial
made little difference to the pooled estimate and did not change
the conclusions of the analysis (Analysis 1.8).
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5. Fixed-effect and random-effects models
Applying a fixed-effect model analysis made little difference to
the pooled effect estimates for both psychiatric admissions (fixed-
effect RR 0.96, 95% CI 0.76 to 1.22) and compulsory admissions
(fixed-effect RR 0.65, 95% CI 0.41 to 1.03). The conclusions of
the analysis remained the same whether a fixed-effect or random-
effects model analysis was used.
D I S C U S S I O N
Summary of main results
In this updated search, we found four studies involving 607 partic-
ipants that met our inclusion criteria. As shown in the Summary of
findings for the main comparison, four studies involving 597 par-
ticipants investigated the impact of user-held records on psychi-
atric hospitalisation and three studies involving 507 participants
investigated compulsory psychiatric hospitalisation. The evidence
suggests that user-held records do not affect the rate of either vol-
untary or involuntary psychiatric admissions.
There were too few investigations of other outcomes to estimate an
effect size, but there is some preliminary evidence to suggest some
beneficial effect on overall costs. There is no evidence of effect
for psychological variables such as psychopathology and patient
satisfaction.
Overall completeness and applicability of
evidence
1. Completeness
With only four studies investigating the core question of the effect
of user-held records on psychiatric hospitalisation, and fewer ex-
amining other outcomes, it is too early to determine the effective-
ness of user-held records.We note with interest two ongoing trials,
due to be completed in 2012, that examine our primary and sec-
ondary outcomes of interest including hospitalisation, costs and
working alliance (Ruchlewska 2009; Thornicroft 2010).
2. Applicability
The only study to find a significant reduction in compulsory psy-
chiatric admissions (Henderson 2004) investigated a form of ad-
vance statement (Henderson 2008), suggesting that both the in-
volvement of the service user in deciding the content and in-
clusion of future treatment wishes or refusals in the record may
have an important effect. However, one other trial (Papageorgiou
2002) also investigated a form of advance statement but found
no effect on the outcomes of interest. There were several differ-
ences between Papageorgiou 2002 and Henderson 2004; firstly,
the Papageorgiou 2002 study was conducted in an inpatient set-
ting with service users who were under a section of the Mental
Health Act and due for discharge. It is conceivable that service
users may have felt compelled to participate in the trial or that
their participation could influence their discharge from the hospi-
tal ward. By contrast, the Henderson 2004 study was conducted
in the community and thus the potential for perceived pressure to
participate was lessened. Secondly, and perhaps more importantly,
the Henderson 2004 study had some direct or indirect involve-
ment (see Henderson 2008) of the clinical team. This suggests
that the efficacy of this type of user-held record may be increased
if clinical teams are also involved in the discussion of the contents
and thus may be better placed to facilitate the service user’s wishes
in the event of a future relapse.
Quality of the evidence
Four studies involving 607 participants and two different types of
interventions were included. The overall quality of the evidence
was moderate. Each of the individual studies were methodologi-
cally quite strong, notwithstanding some gaps in reporting of ran-
domisation and blinding procedures. However, there were too few
studies addressing each outcome of interest to reach a robust con-
clusion regarding the effectiveness of user-held records.
There was a great deal of heterogeneity in both the outcomes re-
ported and their measurement, which prevented synthesis of most
outcomes. Additionally, we believe the between-study variability
for the psychiatric hospital admissions and compulsory psychi-
atric admission outcomes resulted in wide confidence intervals for
these estimations. We therefore downgraded the precision rating
for these estimations in the Summary of findings for the main
comparison. Only one study (Henderson 2004) found a signifi-
cant reduction in compulsory psychiatric admissions.
Potential biases in the review process
The search for studies was rigorous, using the Cochrane database,
reference chaining, grey literature searching and contact with topic
experts. One study was identified in a trial registry entry from the
early 2000s, but neither reports of findings nor the authors could
be located. It is unlikely that this trial would strongly affect our
results as the primary outcomes were only of secondary interest
to this review (for example, health behaviours and psychological
variables such as locus of control). Study selection and data extrac-
tion were conducted separately by two authors and confirmed by
a third, and thus the risk of bias in study selection and extraction
is limited. Authors of included studies were contacted for infor-
mation regarding gaps in the reports of methods but the informa-
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tion was not available. Without this information, the risk of bias
is inconclusive and noted as such in the risk of bias tables.
Agreements and disagreements with other
studies or reviews
We know of one other Cochrane Review in this topic area
(Campbell 2010), a review of Advance Treatment Directives. This
review included two studies that are also included in this review
(Henderson 2004; Papageorgiou 2002). The authors shared our
conclusion that there is insufficient evidence to make a robust
conclusion about the impact of such interventions.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
1. For clinicians
The current state of the evidence suggests that practitioners should
be wary of user-held information systems until their effects have
been more thoroughly evaluated with respect to hospital admis-
sions and other outcomes (see ’Implications for research’). In the
meantime, any decision about whether to use such systems must
be made based on clinical judgement and in the light of current
mental health care legislation unsupported by trial-based evidence.
This lack of evidence should be made clear to patients (see below).
Clinicians interested in this question may wish to participate in
clinical trials to test the effects of user-held information systems.
2. For people with psychotic illnesses
If a user of services with a diagnosis of a psychotic illness is offered
the choice of holding clinical information regarding their care and
treatment, it should be on the understanding that, currently, no
evidence exists as to whether this helps or harms, although some
patients report finding it useful. It would be understandable if
users of services who are interested in establishing whether they
and others would be better off or not with such information ask
to be included in a randomised controlled trial.
3. For managers and policymakers
A policy that mandates the provision of information to patients
on their care plan is not based on evidence from randomised con-
trolled trials; nor is there any evidence for or against promoting
the holding of personalised clinical information by patients with a
diagnosis of psychotic illness. Managers and policymakers should
encourage randomised controlled trials of this potentially inex-
pensive but potent intervention.
Implications for research
1. General
Registration of trials before anyone is randomised would ensure
that participants could be confident that people would know that
the study had at least taken place. Unique study numbers would
help researchers identify single studies from multiple publications
and reduce the risk of duplicating the reporting of data. Compli-
ance with CONSORTwould help clarify methodology and many
outcomes. Failure to do this results in both loss of data and con-
fusion in the results. Finally, working with the ALLTRIALS ini-
tiative would ensure all data from relevant randomised trials were
available.
2. Specific
2.1 Reviews
Three excluded studies are of interest to this broad area and would
fit into other related relevant systematic reviews
Proposed title Excluded study tag
Pre-consultation decision aids in the routine care of people with
severe mental illness
Van Os 2004; Hamann 2006
Psychoeducation initiatives in the routine care of people with se-
vere mental illness
Borell 1995
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2.2 Trials
The findings of this updated review suggest that the evidence gap
remains regarding user-held, personalised, accessible clinical in-
formation for people with psychotic illnesses. Since the cost of
such information systems is low and their use seems acceptable
to some patients, it is likely that interest in user-held records will
grow. It cannot be assumed, however, that user-held information is
beneficial and cost effective without evidence from well planned,
conducted and reported randomised trials.
As noted, two large trials are underway and are due to report find-
ings shortly. Both are investigating a form of advance statement.
The CRIMSON trial (Thornicroft 2010) is a large effectiveness
trial of the Joint Crisis Plan intervention, following on from the
Henderson 2004 trial reported in this review. Such a large scale
trial is likely to provide important evidence regarding both the
effectiveness and acceptability of these types of intervention in
a range of treatment settings. Similarly, the Ruchlewska 2009 is
underway in the Netherlands and is comparing both service user
facilitated and clinician facilitated joint crisis plans with treatment
as usual. This important trial is likely to add to the understanding
of the mechanism of action of such interventions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Henderson 2004
Methods Allocation: randomised.
Blindness: single.
Duration: 15 months.
Raters: independent.
Setting: eight community mental health teams, South London and Kent (UK)
Participants Diagnosis: 100% psychosis (including schizophrenia spectrum and bipolar disorders
using OPCRIT checklist).
N=160.
History: at least one previous psychiatric admission.
Sex: 94 M, 66 F.
Age: over 18 years, mean years (SD) intervention group 39.5 (12.1); control group: 38.
6 (10.6)
Inclusions: in contactwith local communitymental health team; admitted to a psychiatric
inpatient service at least once in previous two years; diagnosis of psychotic illness or
bipolar affective disorder without psychotic symptoms.
Exclusions: current inpatients, unable to give informed consent
Interventions 1. The ’Joint Crisis Plan’ (JCP) intervention: The JCP is developed by a service user
together with their treatment team and facilitated by a member of the research team.
The JCP is held by the user and contains his or her choice of information, which can
include an advance agreement for treatment preferences for any future psychiatric relapse
or crisis, n=80
2. Treatment As Usual (as stipulated by the UK’s Care Programme Approach) and in-
formation leaflets about local services, and relevant policies, n=80
Outcomes Psychiatric hospital admission.
Compulsory hospital admission.
Length of psychiatric admission.
Length of compulsory admission.
Economic costs (collected using modified version of ’client service receipt inventory’)*
Notes *Published as separate paper (Flood 2006).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised - allocation sequence was gen-
erated by using minimization, stratified by
team and by severity of patients’ condition
(standard versus enhanced CPA) to ensure
even distribution of these features whichwe
expected would influence the production
of the plan and its use by staff
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Henderson 2004 (Continued)
Allocation concealment (selection bias) Low risk Predictability of allocation by the mini-
mization process was occasionally a prob-
lem (when batches of similar patients were
forwarded for allocation). To avoid this,
ML reassigned the allocation of one pa-
tient, chosen at random,within each batch,
before we reverted to minimization. When
a patient was recruited, the project worker
requested allocation by email, which was
returned by a statistician as intervention or
control group. Allocation was not revealed
to the investigator
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Single blind - “the investigator was blind
to allocation” (p1). The nature of the inter-
vention meant that the participants could
not be blinded to allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk One investigator (CH) collected follow-up
data and was blinded to treatment group
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information on hospital admissions was
available for all participants. Bed days was
missing from one admission
Selective reporting (reporting bias) Low risk Yes - all outcomes reported.
Other bias Unclear risk None detected.
Lester 2003
Methods Allocation: cluster randomisation (at GP practice level).
Blindness: single.
Duration: 12 months.
Raters: independent.
Setting: six community mental health localities, Birmingham (UK)
Participants Diagnosis: 100% schizophrenia.
N=201.
History: receiving shared care (primary and secondary care) in North Birmingham.
Sex: 125 M, 76 F.
Age: over 18 years, mean years (SD)=46 (11.8).
Exclusions: learning disability, organic brain disease, and key worker concerns (e.g.,
current hospitalisation)
28User-held personalised information for routine care of people with severe mental illness (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lester 2003 (Continued)
Interventions 1. “Patient held record” was a loose-leaf record, containing sections for personal details,
appointments, medication, basic health information, personal and emergency contact
numbers, early warning symptoms and a diary section to record patient, carer and pro-
fessional comments. The record was given to intervention participants at the time of
recruitment, n=100
2. Treatment as usual*, n=101.
Outcomes Psychiatric hospital admission.
Compulsory hospital admission.
Length of psychiatric admission.
Outpatient attendance.
Non-mental health referrals; home treatment use.
Psychopathology (K&G).
Satisfaction with community mental health teams (VSSS).
Unable to use -
Service use: outpatient attendance; home treatment teamuse; non-mental health referrals
Notes *No description given.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “176 general practices… were randomised
by one of the authors (TA) to either in-
tervention or control, using a computer
generated randomnumber schedule. These
practices were stratified by list size and the
number of people with schizophrenia, us-
ing minimization to adjust for imbalances
within the strata.”
Allocation concealment (selection bias) Low risk “To minimize selection bias, recruitment
was undertaken on each day of the week
over a four to eight week period depending
on team caseloads. Within each team, pa-
tients were approached consecutively”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of participants was not possible.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors of psychopathology
were blinded. Satisfaction was a patient
self-report and therefore may be subject to
bias as patients were not blinded
29User-held personalised information for routine care of people with severe mental illness (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lester 2003 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Up to 8 from intervention group (2 deaths;
5 refusals; 1 in prison) and 2 from control
group. Unlikely to be related to the inter-
vention
Selective reporting (reporting bias) Low risk No protocol available.
Other bias Unclear risk None detected.
Papageorgiou 2002
Methods Allocation: randomised.
Blindness: none.
Duration: 12 months.
Raters: independent researchers.
Setting:
Participants Diagnosis: 63% psychosis, 28% depression/bipolar; 8% other.
N=156.
History: receiving compulsory treatment under Section 2, 3, 4 of theMental Health Act
(i.e., formally admitted).
Sex: 83 M, 73 F.
Age: over 18 years, mean years (SD): Intervention: 35.5 (11.3); control: 36.3 (12.6).
Exclusions: specialised sections; pending transfer from hospital; organic brain disease
Interventions 1. Advance Directive (AD) in the form of a booklet entitled Preferences for Care. Con-
taining: contact details of patient, treatment team; and seven statements on future pref-
erences for treatment. Patients who did not want to write in the booklet themselves,
dictated their preferences to the researcher. A rider printed at the end of the booklet
indicated that professionals were not legally bound to comply with preferences for care.
Copies given to keyworker and GP, n=80
2. Standard community psychiatric care (coordinated care programme delivered by a
multi-disciplinary team), n=81
Outcomes Psychiatric hospital admission.
Compulsory hospital admission.
Length of compulsory admission.
Psychopathology (BASIS-32; skewed, summary data only).
Satisfaction (VSSS - adapted brief version).
Unable to use -
Decision making ability (Self-Efficacy Scale; no summary data)
Notes Participants who were receiving compulsory treatment under a section of the Mental
Health Act were recruited from an inpatient setting in London
Risk of bias
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Papageorgiou 2002 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “We allocated patients randomly using
a block design, stratified according to
whether this was the patient’s first ever
or subsequent sectioning. Blocks of twelve
random combinations (six experimental,
six control) were prepared and sealed in en-
velopes”
Allocation concealment (selection bias) Low risk Sealed envelopes. Research assistants tele-
phoned an independent colleague to select
the next envelope
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk It was not possible to blind participants. It
was also impossible to mask the research
assistants to the patient’s allocation as they
were required to assist patients to make a
directive in those allocated to the interven-
tion group. However, systematic bias was
unlikely as the primary outcome concerned
compulsory hospital admission andwas not
based on any later assessment by the re-
searcher
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk As above.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 75% of intervention group and 71% of the
control group were assessed at follow-up.
Missing outcome data are balanced across
the intervention groups and for similar rea-
sons
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk None detected.
Warner 2000
Methods Allocation: cluster randomised (at GP practice level).
Blindness: not reported.
Duration: 12 months.
Raters: not reported.
Participants Diagnosis: 42%psychosis, 12%bipolar, 22%depression, personality disorder 10%, 13%
other.
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Warner 2000 (Continued)
N=90.
History: long-term mental illness (either psychosis, severe non-psychotic disorder, severe
personality disorder, functional impairments), registered with GP and receiving care
from mental health professional.
Sex: 36 M, 54 F.
Age: 18-65 years, mean years (SD): intervention=36 (12.5); control=41(12.6).
Exclusions: none reported.
Interventions 1. Given a shared care booklet which contained: contact details of participant, GP
and psychiatrist, social workers etc; brief clinical notes and medication details; future
appointments, n=55
2. Treatment as usual: care from the primary and hospital teams, n=35
Outcomes *Psychiatric hospital admission.
Length of psychiatric admission (days).
Psychopathology (BASIS-32 and BPRS, skew).
Client satisfaction (CSQ, skew).
*Service use: outpatient attendance.
Notes *This study did not account for clustering in results; therefore, outcomes marked with
(*) symbol indicate the presence of a probable unit of analysis error
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Practices were randomised to shared care
or control status using a computer- gener-
ated algorithm (practices were number se-
quentially based on alphabetical order)”
Allocation concealment (selection bias) Unclear risk Unclear. It was unclear if researchers re-
cruiting participants were aware of which
GP practice the participant was registered
with
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear. It was not possible to blind partic-
ipants.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not clear who rated the outcome mea-
sures and if they were blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Missing data not reported in sufficient de-
tail.
Selective reporting (reporting bias) Unclear risk No protocol available.
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Warner 2000 (Continued)
Other bias Unclear risk None detected.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Backlar 1996 Allocation: not random, case series.
Borell 1995 Allocation: randomised.
Participants: adults with serious mental illnesses.
Intervention: records not personalised.
Cotgrove 1995 Allocation: randomised.
Participants: those with a history of deliberate self harm, not psychosis
Essex 1990 Allocation: not random, case series.
Hamann 2006 Allocation: randomised.
Participants:adults with serious mental illnesses.
Intervention: records not personalised.
Liaw 1998 Allocation: randomised.
Participants: those with chronic health problems, not psychosis
Morgan 1993 Allocation: randomised.
Participants: those with a history of deliberate self harm, not psychosis
Pickersgill 1998 Allocation: not random, case series.
Reuler 1991 Allocation: not random, case series.
Stafford 1997 Allocation: not random, case series.
Sutherby 1999 Allocation: not random, case series.
Swanson 2008 Allocation: not random, case series.
Van Os 2004 Allocation: randomised.
Participants: adults with serious mental illnesses.
Intervention: records not user-held.
Wolf 1996 Allocation: not random, case series.
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Characteristics of studies awaiting assessment [ordered by study ID]
Swanson 2006
Methods Allocation: randomised.
Blindness: non-reported.
Duration: 1 month.
Raters: non-reported.
Participants Diagnosis: 59% schizophrenia/psychosis; 27% bipolar disorder; 14% depression with psychotic features.
N=469.
History: receiving community based treatment through one of two programs in North Carolina.
Sex: 40% M, 60% F.
Age: 18 to 65 years; mean (sd): 42 years (10.7).
Exclusions: unable to give informed consent.
Interventions 1. Facilitated-Psychiatric Advance Directive (F-PAD) which is a semi structured, manualised interview and guided
discussionof choices involved in anticipatorymental health treatment planning.The intervention includes orientation
to concepts related to psychiatric advance directives, review of past treatment experiences, and documentation of
future treatment preferences. The core of the intervention is a semi-structured interview and guided discussion of
choices involved in planning for mental health care during periods of incapacity. If the participants wishes to prepare
the relevant legal psychiatric advance directive documents, the facilitator helps with the completion of the forms
2. Given an introduction to psychiatric advance directives, written materials describing the purpose of advance
directives, copies of standard forms for psychiatric advance directives and the toll-free telephone number of the local
consumer organisation that provides consultation to persons who wish to prepare psychiatric advance directives
Outcomes Working Alliance at one month (Working Alliance Inventory; unable to use as no means or SDs reported)
Needs for treatment (MentalHealth Statistic Improvement ProgramConsumer Survey Index of treatment satisfaction;
unable to use as no means or SDs reported)
Decisional capacity* (DCAT-PAD; unable to use as no means or SDs reported)
Notes * Published in separate paper Elbogen 2007.
We contacted the study authors to obtain summary statistics for each group relevant to our outcomes of interest;
however, we received no reply
Characteristics of ongoing studies [ordered by study ID]
Ruchlewska 2009
Trial name or title The effects of crisis plans for patients with psychotic and bipolar disorders: a randomised controlled trial
Methods Randomised controlled trial
Participants Outpatients with psychotic or bipolar disorders
Interventions Crisis plan made with advocate, Crisis plan made with own clinician, no crisis plan
Outcomes Number of emergency visits, (involuntary) admissions and length of stay in hospital
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Ruchlewska 2009 (Continued)
Starting date 2006
Contact information j.ruchlewska@erasmusmc.nl
Notes At analysis stage October 2011
Thornicroft 2010
Trial name or title CRIMSON: A randomised controlled trial of joint crisis plans to reduce compulsory treatment of people
with psychosis
Methods Multi-centre, single-blind, individual level randomised controlled trial
Participants 540 individuals with psychotic disorders
Interventions Joint Crisis Plan compared with treatment as usual
Outcomes Involuntary admissions to hospital
Starting date October 2007
Contact information Graham.Thornicroft@kcl.ac.uk
Notes Finishing data collection November 2011
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D A T A A N D A N A L Y S E S
Comparison 1. User-held information versus standard information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Psychiatric hospital admission:
1. Psychiatric admission
4 Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 any admission 4 597 Risk Ratio (IV, Random, 95% CI) 0.99 [0.71, 1.38]
1.2 compulsory admission 3 507 Risk Ratio (IV, Random, 95% CI) 0.64 [0.37, 1.10]
2 Psychiatric hospital admission:
2a. Days in hospital
(compulsory only, by range of
days)
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
2.1 0 days 1 156 Risk Ratio (IV, Random, 95% CI) 1.02 [0.87, 1.20]
2.2 1-100 days 1 156 Risk Ratio (IV, Random, 95% CI) 0.70 [0.33, 1.47]
2.3 101-365 days 1 156 Risk Ratio (IV, Random, 95% CI) 2.44 [0.49, 12.18]
3 Psychiatric hospital admission:
2b. Days in hospital (skewed
data)
Other data No numeric data
3.1 any admission Other data No numeric data
3.2 compulsory admission Other data No numeric data
4 Mental state: Scores (high=
worse, skewed data)
Other data No numeric data
4.1 BPRS Other data No numeric data
4.2 BASIS-32 Other data No numeric data
4.3 K&G Other data No numeric data
5 Satisfaction: Scores (high=better) Other data No numeric data
5.1 hospital service satisfaction
(VSSS, skewed data)
Other data No numeric data
5.2 client satisfaction (CSQ,
non skewed but data analysed
taking clustering into account)
Other data No numeric data
6 Service use 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
6.1 outpatient attendance 2 281 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.92, 1.29]
6.2 home treatment use 1 191 Risk Ratio (M-H, Random, 95% CI) 0.72 [0.21, 2.46]
6.3 non-mental health
referrals
1 191 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.59, 1.98]
7 Economic costs of care (£ - client
service receipt inventory, skew)
Other data No numeric data
8 Sensitivity analysis: Psychiatric
hospital admission: adjusting
for clustering
4 Risk Ratio (IV, Random, 95% CI) Subtotals only
8.1 adjusted for cluster effects 4 566 Risk Ratio (IV, Random, 95% CI) 0.97 [0.70, 1.35]
8.2 not adjusted for cluster
effects
4 597 Risk Ratio (IV, Random, 95% CI) 0.99 [0.71, 1.38]
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WH A T ’ S N E W
Date Event Description
10 September 2013 New citation required and conclusions have changed Conclusions changed: no evidence of effect with hos-
pitalisations,
but evidence gap remains for other outcomes.
2 August 2011 New search has been performed New search conducted August 2011. Four trials are
now included in this review
H I S T O R Y
Date Event Description
13 April 2011 Amended Minor update.
15 February 2010 Amended Minor update.
5 November 2008 Amended Update.
31 October 2008 Amended Converted to new review format.
31 October 2005 Amended Minor update.
24 September 2003 New citation required but conclusions have not
changed
Updated.
26 October 1999 New citation required and conclusions have changed Review first published.
C O N T R I B U T I O N S O F A U T H O R S
Simone Farrelly - study selection, data extraction, data analysis, completion of report.
Gill Brown - study selection, data extraction.
Clare Flach - data analysis, completion of report.
Claire Henderson - original protocol writing, confirmation of trial selection and data extraction, completion of report.
Richard Laugharne and Elizabeth Barley - completion of report.
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D E C L A R A T I O N S O F I N T E R E S T
Simone Farrelly, Gill Brown, Clare Flach and Claire Henderson all worked on the ongoing trial CRIMSON (Thornicroft 2010), a trial
of Joint Crisis Plans funded by the Medical Research Council (UK). Claire Henderson also worked on one of the studies included in
this review (Henderson 2004).
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Medical Research Council, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We were concerned about splitting outcome data for the results at 12 months; the review authors appreciate that time frames were
specified in the protocol, but we made the decision that it does not fairly represent the data by making a distinction between three
studies with a 12-month follow-up and one study with a 15-month follow-up. We think that representing the data in this way may
lead to misleading messages about time trends that we do not have evidence for.
This review update modified the previous inclusion criteria by specifying a minimum diagnostic threshold for studies with a mixture
of diagnoses in their samples.
We have also updated the methods section of this review to reflect advances in Cochrane methodology.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Health Records, Personal; Hospitalization [statistics & numerical data]; Patient Access to Records; Psychotic Disorders [∗therapy];
Randomized Controlled Trials as Topic
MeSH check words
Adult; Humans
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